High burden of clonal mast cell disorders and hereditary alpha-tryptasemia in patients who need Hymenoptera venom immunotherapy. Korosec P, Sturm GJ, Lyons JJ, Marolt TP, et al. Allergy 2024;79:2458-2469.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Korosec P, Sturm GJ, Lyons JJ, Marolt TP, et al. High burden of clonal mast cell disorders and hereditary alpha-tryptasemia in patients who need Hymenoptera venom immunotherapy. Allergy 2024;79:2458-2469.
PMID: 38477502